EMEA-003475-PIP01-23 - paediatric investigation plan
Naproxen
Paracetamol
PIPHuman
Key facts
- Active Substance
- Naproxen
- Paracetamol
- Therapeutic area
- Nervous system disorders
- Decision number
- P/0472/2023
- PIP number
- EMEA-003475-PIP01-23
- Pharmaceutical form(s)
- Tablet
- Condition(s) / indication(s)
- Treatment of acute pain
- Treatment of febrile disorders
- Treatment of rheumatoid arthritis
- Route(s) of administration
- Oral use
- Contact for public enquiries
GSK Consumer Healthcare Export Limited
Email: CHPK.MEDINFO@haleon.com
Tel. +0800 7838881- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date